GlassScriptPhysician profile
Daniel Brennan Vine
NPI 1841219375
$1,238.23
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.47 · 2020: $104 · 2021: $75.82 · 2022: $41.88 · 2023: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $673 · Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $672.93 |
| Food and Beverage | $302.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,012.80 | 2019-2023 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Sk Life Science, INC. | $118.10 | 2020-2022 | |
| Greenwich Biosciences, INC. | $47.89 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $24.27 | 2023 | Epidiolex |
| Sunovion Pharmaceuticals INC. | $21.21 | 2019 | |
| Neurelis, INC. | $13.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Vine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.